Get started
Work

Supplementary Table S3 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Table S3. Clinicopathological information of the surgical NSCLC patients (n = 14) used to validate the PDTO findings.
DOI: 10.1158/1078-0432.26926624
Authors: Kanve N. Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum, Mohamed Gadelkarim, Murugesan Raju, Akhil Srivastava, Guangfu Li, Wesley C. Warren, Chi-Ren Shyu, Feng Gao, Matthew A. Ciorba, Jonathan B. Mitchem, Satyanarayana Rachagani, Jussuf T. Kaifi
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4402173003
Cites:
Cited by:
Related to: 10